>
For America to Survive: We Need One Language, English!
5 MINS AGO! This LEAKED News Is HORRIBLE for GOLD & SILVER Investors
Is Trump About To Invade Cuba?
What you thought on my first 24-hour plan for SHTF...And some great comments.
A laser just photographed objects through six feet of concrete
Elon Musk's Next-Gen Motor Destroy Entire EV Industry
China's disputed satellite refueling heralds new space war era
BYD Will Put Solid-State Batteries In An EV Next Year: Executive
FDA-cleared exoskeleton puts spinal-cord patients back on their feet
Your Robotic Vacuum Is Watching You -- Could It Someday Testify Against You in Court?
Why Unigrid's Sodium-Ion Batteries Are the Game-Changer for Off-Grid Energy Storage
This Battery On Wheels Makes Any Diesel Truck Electric In 5 Minutes
Mass-Production of AI Infrastructure – Speed Up by 10X
3D-printed Martian mud homes look critical for life beyond Earth

3 patients experienced complete remission after regularly taking fenbendazole.
But the cancer industry seems to hate it because it only costs about $11 per week.
Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects.
The case series highlights the remarkable stories of three cancer patients who achieved miraculous recoveries with fenbendazole after exhausting all conventional therapies.
After analyzing these cases, the abstract concluded, "FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies."
Adding to the growing evidence in support of fendendazole's use case against cancer, an Oklahoma man credited his miraculous cancer recovery to the pet med after overcoming terminal small cell lung cancer, defying a less than 1% survival rate and leaving doctors baffled.
This story is truly remarkable. Watch.